Faculty profile

Raymond Andersen

ResearcherGenome Sciences CentreUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Raymond Andersen

Researcher

Genome Sciences Centre

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2016.
Principal investigator on 22 research grants (18 NSERC, 4 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Androgen Receptor Drug Development Natural Compounds Prostate Cancer Xenografts

Latest papers

Latonduine Analogs Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Trafficking through the Modulation of Poly-ADP Ribose Polymerase 3 and Poly-ADP Ribose Polymerase 16 Activity.
Molecular pharmacology · 2016
Quantitative proteomic analysis of sokotrasterol sulfate-stimulated primary human endothelial cells.
Molecular & cellular proteomics : MCP · 2005

All 2 publications

Latest funding

Catalyzing One Health Research on Highly Pathogenic H5N1 Avian Influenza A (HPAI H5N1) Viruses: An integrated transdisciplinary approach using translational genomics, AI-driven modeling, and phenotypic profiling
CIHR · 2024 · Co-investigator
$150,000
Assembly of a pseudo-peptide active against Gram-negative bacteria
CIHR · 2024 · Co-investigator
$100,000
Pre-clinical development of a novel class of broad-spectrum natural product antivirals
CIHR · 2023 · Co-investigator
$787,950

All 68 grants and awards

Catalyzing One Health Research on Highly Pathogenic H5N1 Avian Influenza A (HPAI H5N1) Viruses: An integrated transdisciplinary approach using translational genomics, AI-driven modeling, and phenotypic profiling

Co-investigatorCIHR2024Catalyst Grant: Avian Influenza OneHealth Research

Principal investigators: Jean, François

Keywords: Antiviral Drugs; Artificial Intelligence (Ai)-Based Molecular Modeling; Cell-Based Assays; H5n1 Structural Proteins; Highly Pathogenic H5n1 Avian Influenza A Viruses; Molecular Virology; One Health Research - H5n1 Viruses; Pseudoviruses; Translational Genomics; Virus-Host Cell Interactions

$150,000

Assembly of a pseudo-peptide active against Gram-negative bacteria

Co-investigatorCIHR2024Project Grant - PA: Antimicrobial Resistance (Bridge Grant)

Principal investigators: Ryan, Katherine S

Keywords: Antibiotic; Bioinformatics; Biosynthesis; Deletion Mutagenesis; Enzymes; Gene Cluster; Genome Mining; Gram-Negative; Mass Spectrometry; Synthetic Biology

$100,000

Pre-clinical development of a novel class of broad-spectrum natural product antivirals

Co-investigatorCIHR2023Project Grant

Principal investigators: Jean, François

Keywords: Animal Models Of Viral Infection; Antiviral Drug Discovery; Antiviral Properties; Broad-Spectrum Antivirals; Emerging Human Viruses Of International Concerns; Host-Directed Antivirals; Medicinal Chemistry; Natural Product Antivirals; Pharmaceutical Properties; Pharmacognosy

$787,950

Critical Clean Water Technologies for Earth System Biogeochemical Research

Co-investigatorNSERC2022Research Tools and Instruments

Principal investigators: Maldonado, Maria

$65,697

COVID-19 Variant Supplement - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.

Co-investigatorCIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 1

Principal investigators: Cherkasov, Artem; Jean, François

Keywords: Drug And Natural Product Repurposing; Enable High-Quality Data On Existing Covid-19 Treatment; Enhance Canadian Engagement In Large Scale Trials; Enhance Engagement With Middle-Income & Low-Income Countries; Evidences For Clinical & Public Health Decision Makers; Idenitfy Remdesivir Synergistic Drugs; National And International Coordination For Sharing Of Data; New Covid-19 Treatment For Interventions And Prevention; Rapid Deployment Of Existing Research Platforms; Sex As A Biological Variable

$50,000

COVID-19 Variant Network - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.

Co-investigatorCIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 2

Principal investigators: Cherkasov, Artem; Jean, François

$90,000

Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.

Co-investigatorCIHR2020Operating Grant: COVID-19 Rapid Research Funding Opportunity - Therapeutics

Principal investigators: Cherkasov, Artem; Jean, François

$2,109,120

Bioactivity Guided Marine Natural Product Discovery Using Phenotypic Assays

Principal investigatorNSERC2018Discovery Grants Program - Individual

Principal investigators: Andersen, Raymond

$288,000

High Resolution ESI Mass Spectrometer

Co-investigatorNSERC2018Research Tools and Instruments

Principal investigators: Ryan, Katherine

$150,000

High Resolution EI Mass Spectrometer

Co-investigatorNSERC2017Research Tools and Instruments

Principal investigators: Sammis, Glenn

$150,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Raymond Andersen

Research

Latest papers

Latest funding

Latonduine Analogs Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Trafficking through the Modulation of Poly-ADP Ribose Polymerase 3 and Poly-ADP Ribose Polymerase 16 Activity.

Quantitative proteomic analysis of sokotrasterol sulfate-stimulated primary human endothelial cells.

Catalyzing One Health Research on Highly Pathogenic H5N1 Avian Influenza A (HPAI H5N1) Viruses: An integrated transdisciplinary approach using translational genomics, AI-driven modeling, and phenotypic profiling

Assembly of a pseudo-peptide active against Gram-negative bacteria

Pre-clinical development of a novel class of broad-spectrum natural product antivirals

Critical Clean Water Technologies for Earth System Biogeochemical Research

COVID-19 Variant Supplement - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.

COVID-19 Variant Network - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.

Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.

Bioactivity Guided Marine Natural Product Discovery Using Phenotypic Assays

High Resolution ESI Mass Spectrometer

High Resolution EI Mass Spectrometer

Frequent collaborators

Aly Karsan